trending Market Intelligence /marketintelligence/en/news-insights/trending/ICPtbj7jX7ip6Fxcfh_FzQ2 content esgSubNav
In This List

Agios Pharmaceuticals CFO joins Editas Medicine board

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


Agios Pharmaceuticals CFO joins Editas Medicine board

Editas Medicine Inc. appointed Andrew Hirsch to its board.

Hirsch, CFO of Agios Pharmaceuticals, will also serve as chairman of the Editas board's audit committee.